Teva and Apotex are entering the Tolvaptan market, while Lupin reports sales growth in North America and India.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva and Apotex are entering the Tolvaptan market, while Lupin reports sales growth in North America and India.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
-
Apotex
Canadian private pharmaceutical company